EverSource Wealth Advisors »

Tscan Therapeutics shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $118 65 1.82
2025-06-30 $98 70 1.40
2025-03-31 $29 21 1.38

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
iShares Gold Trust ETF Etf (IAU)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Microsoft Corp Stock (MSFT)
Tesla Stock (TSLA)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Total Stock Market Etf Etf (VTI)
Broadcom Stock (AVGO)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for EverSource Wealth Advisors

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
BlackRock
Vanguard Group
Propel Bio Management
Standard Life Aberdeen
Deer Management
Alphabet
Simplify Asset Management
Morgan Stanley
Renaissance Technologies
DC Funds
Tang Capital Management
Geode Capital Management

View all funds holding Tscan Therapeutics